Report of the Task Force on the Clinical Use of Factor IX Concentrates

• References

• 1 Cash J. D, Dalton R. G, Mtodleton S, Smith J. K. 1975; Studies on the thrombogenicity of Scottish Factor IX concentrates in dogs. Thrombosis et Diathesis Haemorrhagica 33: 632.
• 2 Hoofnagle J. H, Aronson D. L, Roberts H. R. 1975; Serological evidence for hepatitis B virus in patients with hemophilia B. A multicenter study. Thrombosis et Diathesis Haemorrhagica 33: 606.
• 3 Kingdon H. S, Lundblad R. L, Veltkamp J. J, Aronson D. L. 1975; Potentially thrombogenic materials in factor IX concentrates. Thrombosis et Diathesis Haemorrhagica 33: 617.
• 4 Kasper C. K. 1975; Thromboembolic complications. Thrombosis et Diathesis Haemorrhagica 33: 640.
• 5 Ménaché D. 1975; a Clinical use of factor IX concentrates. Thrombosis et Diathesis Haemorrhagica 33: 597.
• 6 Ménaché D. 1975; b Factor IX concentrates. Thrombosis et Diathesis Haemorrhagica 33: 600.
• 7 Ménaché D, Roberts H. R. 1975; Summary report and recommendations of the Task Force members and consultants. Thrombosis et Diathesis Haemorrhagica 33: 645.
• 8 Roberts H. R, Blatt P. M. 1975; Post transfusion hepatitis following the use of prothrombin complex concentrates. Thrombosis et Diathesis Haemorrhagica 33: 606.